Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides - LeGuenno, G; Mahr, A; Pagnoux, CFrench Vasculitis Study Group (Arthritis Rheum, 2011)
et al.